Allianz Asset Management
INSY

Allianz Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Allianz Asset Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,356
Closed -$238K – 2557
2015
Q3 		$238K Sell
8,356
-197,660
-96% -$7.27M ﹤0.01% 2246
2015
Q2 		$7.4M Sell
206,016
-187,922
-48% -$5.85M 0.01% 1228
2015
Q1 		$11.4M Sell
393,938
-15,750
-4% -$417K 0.01% 889
2014
Q4 		$8.64M Buy
409,688
+23,382
+6% +$462K 0.01% 1012
2014
Q3 		$7.49M Buy
386,306
+11,602
+3% +$182K 0.01% 936
2014
Q2 		$5.85M Buy
374,704
+51,354
+16% +$830K 0.01% 891
2014
Q1 		$6.7M Sell
323,350
-144,338
-31% -$2.86M 0.01% 869
2013
Q4 		$6.04M Sell
467,688
-313,458
-40% -$4.35M 0.01% 890
2013
Q3 		$9.11M Buy
+781,146
New +$6.41M 0.01% 705

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Allianz Asset Management's INSY Position: Q4 2015 in Review

Allianz Asset Management sold out of Insys Therapeutics, Inc. (INSY) in Q4 2015, closing a stake of 8,356 shares — an estimated $238K sold.

Allianz Asset Management first reported a position in INSY in Q3 2013 and held it in 9 quarters. The position peaked at $11.4M in Q1 2015. 154 funds tracked by Wall St. Rank hold INSY as of Q4 2015.

  • Allianz Asset Management reported no remaining Insys Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • Allianz Asset Management sold 8,356 Insys Therapeutics, Inc. shares in Q4 2015, an estimated $238K.
  • Allianz Asset Management first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 9 quarters.
  • Allianz Asset Management's Insys Therapeutics, Inc. position peaked at $11.4M in Q1 2015.
  • 154 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2015.

Based on Allianz Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.